3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Intraocular Lymphoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
fludarabine phosphate
31
Peripheral Blood Stem Cell Transplantation
26
Cyclophosphamide
25
Mycophenolic Acid
24
Whole-Body Irradiation
23
Busulfan
21
Tacrolimus
19
Cyclosporine
19
Antilymphocyte Serum
14
Methotrexate
13
Imatinib Mesylate
12
Cord Blood Stem Cell Transplantation
11
Melphalan
10
Dasatinib
10
Cyclosporins
8
nilotinib
7
Methylprednisolone
7
Etoposide
7
Radiotherapy
6
Filgrastim
6
Alemtuzumab
6
Sirolimus
5
thymoglobulin
4
sargramostim
4
bosutinib
4
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
fludarabine
3
Thiotepa
3
Rituximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic-Phase
×
oblimersen
×
Clear all
No trials found.